AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2016
Feb 19, 2016
34117_dirs_2016-02-19_248e025f-c891-4aef-b702-81180542f1d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-02-18
Reporting Person: KUMAR AMIT (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-18 | Employee Stock Options (Right to Buy) | $2.92 | A | 200000 | Acquired | 2026-02-18 | Common Stock (200000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
F2: The option vests in 36 consecutive monthly installments beginning on March 31, 2016.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6